F16.929 Hallucinogen use, unspecified with intoxication, unspecified

Name of the Condition

• Hallucinogen Use, Unspecified with Intoxication, Unspecified
• Medical Term: ICD-10-CM F16.929

Summary

Hallucinogen use, unspecified with intoxication, unspecified refers to the acute effects of hallucinogenic substance use resulting in clinically significant intoxication, where the specific pattern of use and any complications are not documented. This code is applied when documentation confirms recent hallucinogen exposure and intoxication symptoms, but does not specify abuse, dependence, withdrawal, or associated complications. It is used for cases where intoxication is present without further classification of the use pattern or adverse outcomes.

Causes

Hallucinogen use, unspecified with intoxication, unspecified typically involves substances that alter perception, mood, or cognitive function, such as LSD, psilocybin, or mescaline. Intoxication occurs due to recent use, leading to temporary physiological and psychological effects. The documentation does not specify a problematic pattern beyond the acute intoxication episode, and no complications are documented.

Risk Factors

• Recreational or experimental use of hallucinogens
• Pre-existing mental health conditions
• Genetic predisposition to substance use disorders
• Social or peer pressure to use drugs
• Access to hallucinogenic substances

Symptoms

• Altered sensory perceptions (e.g., visual or auditory hallucinations)
• Distorted sense of reality or time
• Mood changes, including euphoria or anxiety
• Impaired judgment or coordination
• Increased heart rate or blood pressure
• Nausea or vomiting
• Paranoia or panic

Diagnosis

Diagnosis requires clinical evaluation of recent hallucinogen use and associated symptoms. Healthcare providers assess for acute intoxication signs, including perceptual changes, mood alterations, and physiological effects. Laboratory tests may be used to detect substance presence, though confirmation often relies on patient history and symptom presentation. Documentation must confirm intoxication without specifying use pattern or complications to apply this code.

Treatment Options

Treatment focuses on managing acute symptoms and ensuring safety. Supportive care, such as monitoring vital signs and providing a calm environment, is common. In severe cases, benzodiazepines may be used for agitation or anxiety. Referral to substance use disorder services is recommended for ongoing care, though this code does not indicate chronic use.

Prognosis and Follow-Up

Prognosis depends on the severity of intoxication and any underlying conditions. Acute symptoms typically resolve within hours to days with supportive care. Follow-up may involve monitoring for residual effects or assessing for substance use patterns. Long-term outcomes vary based on frequency of use and individual health factors.

Complications

• Severe psychological distress (e.g., panic attacks, psychosis)
• Accidental injury due to impaired judgment
• Cardiovascular issues (e.g., hypertension, arrhythmias)
• Respiratory depression (rare with hallucinogens but possible with combinations)
• Worsening of pre-existing mental health conditions

Lifestyle & Prevention

• Avoiding hallucinogen use reduces risk of intoxication.
• Education on substance effects and risks may deter use.
• Seeking help for substance use concerns early can prevent complications.
• Maintaining a supportive social environment may reduce peer pressure.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe symptoms like chest pain, difficulty breathing, extreme agitation, or suicidal thoughts. Consult a healthcare provider for persistent psychological effects or concerns about substance use patterns.

Tips for Medical Coders

Document recent hallucinogen use and acute intoxication symptoms clearly. Ensure no specific use pattern (e.g., abuse, dependence) or complications are mentioned to justify this code. Verify that the unspecified nature of both use and intoxication aligns with clinical documentation.